About: Arcturus Therapeutics Holdings Inc., a messenger RNA medicines company, focuses on the development of liver and respiratory rare disease therapeutics. Its technology platforms include STARR, a self-amplifying mRNA technology platform, and LUNAR, a lipid-mediated delivery system. The company also develops ARCT-032 (LUNAR-CF), an mRNA therapeutic candidate for cystic fibrosis that is in Phase 2 clinical development; and ARCT-810 (LUNAR-OTC), which is in Phase 2 clinical development to address ornithine transcarbamylase (OTC) deficiency. In addition, it develops KOSTAIVE, a self-amplifying RNA vaccine for COVID-19; ARCT-2138 (LUNAR-FLU), which is in Phase1 clinical trial for the treatment of seasonal influenza; and ARCT-2304 (LUNAR-H5N1) that is in Phase1 clinical trial for the treatment of Pandemic Influenza. Arcturus Therapeutics Holdings Inc. was founded in 2013 and is headquartered in San Diego, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $12.04 (-4.56%)
ARCT NASDAQ Arcturus Therapeutics Holdings Inc
Arcturus Therapeutics Holdings Inc share price
ARCT price activity
Last Price
$12.040
Change (24hr)
-0.58 USD (-4.56%)
Volume
226.25K
Volume (4w avg)
-
Open
$12.42
Day Range
$12.04 - $12.42
Previous Close
$12.61
Last Trade
13 Oct, 6:02 pm GMT+0
Delayed
13 Oct, 6:02 pm GMT+0
ARCT price performance
Delayed
13 Oct, 6:02 pm GMT+0
ARCT Market Signals